Abstract

BackgroundOrbital mucormycosis is a rare but potentially severe and troublesome invasive fungal infection that could be occurred even in healthy individuals. The initial clinical presentation is similar to bacterial pre-septal or septal cellulitis, especially in early stages.Case presentationHerein, we describe the successful management of a series of five cases presenting with orbital mucormycosis in previously healthy children.ConclusionsOrbital mucormycosis is extremely rare in healthy children and maybe life-threatening when diagnosis delayed given a similar clinical presentation with bacterial septal cellulitis. Intravenous antifungal therapy with amphotericin B and timely surgical drainage is live-saving.

Highlights

  • Mucormycosis is the third most common invasive fungal infections following candidiasis and aspergillosis [1]

  • Invasive forms of mucormycosis have been described and well-known in immunocompromised hosts, such as bone marrow transplantation (BMT), aggressive immunosuppressive therapy in hematological malignancies and diabetic patients [3, 13,14,15], it is scarce in healthy individuals [2, 3, 8,9,10,11, 16]

  • Based on a retrospective global analysis of 101 cases of mucormycosis in France reported by Lanternier et al, all except one have underlying risk factors [17]

Read more

Summary

Introduction

Mucormycosis is the third most common invasive fungal infections following candidiasis and aspergillosis [1]. Discussion and conclusion we report orbital mucormycosis in five immunocompetent children without underling disease or known immunodeficiency successfully managed with medical and surgical interventions.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.